About: The impact of renin–angiotensin–aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The impact of renin–angiotensin–aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 21 December 2011

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 2012 (uk) article scientifique publié en 2011 (fr) im April 2012 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 21 December 2011 (en) artículu científicu espublizáu n'avientu de 2011 (ast)
publication date	wds:Q58977867-43118B30-A11F-43B4-8CDE-A3E570D0896E
publication date	2011-12-21 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58977867-3E90FD36-6218-4BE4-AFE9-D805401A60DE
language of work or name	English
exact match	wds:Q58977867-94A0FF00-E3F0-4363-85C7-8171A13E3F51
exact match	https://scigraph.springernature.com/pub.10.1038/ki.2011.413
cites work	wds:Q58977867-0AF4A849-37C0-4361-BF4F-C0661ABD8DBF wds:Q58977867-0F121130-FF9E-42B4-90FA-D27A87AAB2D5 wds:Q58977867-15B72BB9-160D-4672-BFE6-70C573AB2F18 wds:Q58977867-1A071D22-AAFA-4F34-BE05-36AD72ADABB1 wds:Q58977867-1D1DCC5A-8686-4ABE-8462-AD2FCBD3ADE1 wds:Q58977867-2284330A-51DE-4CBF-9A99-92476395C4E7 wds:Q58977867-318A5164-341A-49C3-8350-6725BFBA2698 wds:Q58977867-395D8D16-7490-4865-B626-2CD8539865E4 wds:Q58977867-4B74288D-C7E6-47E7-8573-04602A6F71DB wds:Q58977867-4F7146A8-87D1-4D75-8275-E727FEB0A529 wds:Q58977867-5CFB6D11-806B-4CF1-A80E-7B65AD71BBD8 wds:Q58977867-6430F085-A323-4140-9E8E-7996AAA3E280 wds:Q58977867-6B80151A-6FF0-4956-8061-C79B61EAD60C wds:Q58977867-70ABEB95-94FD-4852-9635-BF179EE42721 wds:Q58977867-80C3A181-618E-467B-BB9A-742BCDE95667 wds:Q58977867-9B3E675D-76FD-4008-9967-A511AD55BA18 wds:Q58977867-B8D0B61C-3C0B-4A95-8DA5-563EA1600B86 wds:Q58977867-C2B19DF8-81F0-4686-AD2A-1E1398F92ACE wds:Q58977867-C36C8AA7-A5CB-44E0-9905-228092A0B101 wds:Q58977867-C4EAC401-DEC5-4FA2-9B8D-47B13D6CFA5C wds:Q58977867-CF9F0607-3CDB-49D6-8D73-A586AF1CE7EC wds:Q58977867-D14B23A5-8780-4BF7-A01F-3BD563FD804C wds:Q58977867-D4B34C1A-09DC-413C-BD68-AD12E3EE807E wds:Q58977867-DC788056-F6F1-4422-BF95-ED59ED60678B wds:Q58977867-DEF61549-126A-4168-9A6F-CC26D1FA9F21 wds:Q58977867-E024FE41-0470-46E5-96DC-EC377A7F0944 wds:Q58977867-E06062B6-B7A6-43AF-8870-B3C290C50D89 wds:Q58977867-FACFBB16-1DE3-4EBA-9D50-6B0BC654C07A
cites work	Systematic review on urine albumin testing for early detection of diabetic complications Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis Comparison of different measures of urinary protein excretion for prediction of renal events Meta-analysis in clinical trials Renal and retinal effects of enalapril and losartan in type 1 diabetes Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials. Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002 Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection The global burden of diabetes and its complications: an emerging pandemic The growing economic burden of diabetic kidney disease Statistical methods can be improved within Cochrane pregnancy and childbirth reviews Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy Lowering blood pressure reduces renal events in type 2 diabetes Effects of monotherapy of temocapril or candesartan with dose increments or combination therapy with both drugs on the suppression of diabetic nephropathy. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysis. Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics Hypertension and non-insulin-dependent diabetes. A comparison between an angiotensin-converting enzyme inhibitor and a calcium antagonist. Olmesartan, microalbuminuria, and type 2 diabetes Twelve shifting paradigms in diabetic renal disease and hypertension The effects of candesartan on diabetes glomerulopathy: a double-blind, placebo-controlled trial A renoprotective effect of low dose losartan in patients with type 2 diabetes.
author name string	wds:Q58977867-0039B1AA-E8DB-4E96-946F-74979EB2CC22 wds:Q58977867-52492823-1F6E-4A5F-A5CF-220E21365DAE wds:Q58977867-A8810FE5-697E-41BB-A1E2-358F83237FBE wds:Q58977867-FFE47BD9-BF9B-4DF7-9BB7-1196FCC51FA5
author name string	Richard J Stevens Andrew J Farmer Kathryn S Taylor Claire L Blacklock
rdfs:label	The impact of renin–angiotensin–aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy (en) The impact of renin–angiotensin–aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy (nl)
skos:prefLabel	The impact of renin–angiotensin–aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy (en) The impact of renin–angiotensin–aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy (nl)
name	The impact of renin–angiotensin–aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy (en) The impact of renin–angiotensin–aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy (nl)
author	wds:Q58977867-3E6048AC-39E0-49B1-9084-73D09A985D16 wds:Q58977867-89746C94-522F-4B68-8EEA-87DDCCCA7EDD wds:Q58977867-C885F744-A300-4082-8AC0-9670EBE42658
author	Chris Pugh Nia Roberts Jennifer Hirst
title	wds:Q58977867-773BB329-424D-483C-8563-C321B0ED4193
title	The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy (en)
page(s)	wds:Q58977867-EBC17EF4-9144-46CF-8F63-76CC8ACDF88A
page(s)	674-683
instance of	wds:Q58977867-9910793A-2760-41F2-A1F0-135C8154E91E wds:Q58977867-e58044cd-38ab-4627-a5ea-a51a8ae5f009
instance of	meta-analysis scholarly article
main subject	wds:Q58977867-82BAC300-2017-46DB-AED0-88EF61927491
main subject	diabetic nephropathy
PubMed ID	wds:Q58977867-A2E81080-3DA7-46A3-865F-A0D566945620

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software